期刊文献+

福辛普利对糖尿病大鼠心功能的保护 被引量:2

Protection of Cardiac Function of Diabetic Rats by Fosinopril
原文传递
导出
摘要 目的:观察福辛普利对糖尿病大鼠心功能、心肌局部血管紧张素Ⅱ(AngⅡ)浓度及转化生长因子(TGF-β1)表达的影响。探讨福辛普利通过AngⅡ和TGF-β1保护心功能的机制。方法:30只SD大鼠,随机取20只大鼠建立糖尿病模型后,再随机分为福辛普利治疗组(干预组)及糖尿病未治疗组(未治疗组),每组10只,另10只作为正常对照组。治疗组以福辛普利15 mg/(kg.d)水溶液灌胃,对照组和未治疗组每天以同等体积清水灌胃。9周后,用超声心动图观察心功能,放射免疫法测定心肌局部AngⅡ的水平,用免疫组织化学法检测心肌细胞中TGF-β1的表达含量。结果:糖尿病未治疗组心肌局部AngⅡ含量显著高于正常对照组(5 367.43±498.28和4 340.67±348.37,P<0.01),福辛普利干预组AngⅡ含量显著降低(4 501.50±129.33,P<0.01)。未治疗组心肌局部的TGF-β1表达显著高于对照组(0.266 5±0.049 3和0.135 2±0.050 7,P<0.01);福辛普利干预后TGF-β1表达则明显降低(0.140 9±0.039 6,P<0.01)。未治疗组心功能明显低于对照组(P<0.01);福辛普利干预组心功能显著改善(P<0.01)。相关分析表明:未治疗组心肌局部AngⅡ含量与心肌TGF-β1表达明显正相关(r=0.802,P<0.05);而AngⅡ的含量和TGF-β1的表达分别与心功能明显负相关(r=-0.832P<0.05,r=-0.776,P<0.05)。结论:福辛普利能通过降低心肌局部AngⅡ含量而减少心肌TGF-β1表达,减轻心功能的恶化。 Objective: To observe the effect of fosinopril on the change of cardiac function, the content of Ang Ⅱ in the rat homogenate of heart muscle and the expression of TGF-β in myocardium in diabetic rats. Methods: A total of 30 SD rats were enrolled in the study, ten of them were set as normal controls, others were injected with STZ to construct diabetic models to study the effect of fosinopril. Doppler echocardiography was adopted to determine the cardiac fuction, and the content of Ang Ⅱ in the myocardium was assayed by radio-immunoassay. By the method of immunochemistry, the expression of TGF-β in the ventricular cells was detected as the index to evaluate the degree of fibrosis. Results: When compared with those of untreated model group, cardiac function (E/A) was significantly improved (P〈0.01), and the expression of TGF-β1 decreased (P〈0.01) in the fosinopril treated group. These two indices were significantly correlated with the content of AngH of heart (r=-0.832, P〈0.05; r=0.802, P〈0.05). Conclusion: Fosino- pril can inhibit the expression of TGF 131 and elevate cardiac function through deceasing the content of Ang Ⅱ of myocardium.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2009年第4期481-483,487,共4页 Medical Journal of Wuhan University
关键词 糖尿病心肌病 血管紧张素Ⅱ 福辛普利 TGF-Β1 Diabetic cardiomyopathy AngiotensinⅡ Fosinopril
作者简介 肖然,女,1982,医学硕士,主要从事心肌保护研究,现在嘉兴学院诊断学教研室工作(浙江嘉兴314001). 通讯作者:熊世熙,男,1957,主任医师,硕士生导师,主要从事心肌保护与代谢综合征研究.
  • 相关文献

参考文献3

二级参考文献13

  • 1[1]Van Hoeven, Factor SM.A comparison of the pathological spectrum of hypertension, diabetic and hypertension diabetic heart disease. Circulation, 1999,82:848
  • 2[2]Sechi LA,Griffin CA, Schambelan M.The cardiac renal Angiotensin system in STZ-induced diabetes. Diabetes, 1994, 43:1 180
  • 3[3]Norton GR, Tsotetsi J, Trifunovic B, et al. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation, 1997,96(6):1 991
  • 4[4]Namba T, Tsutsui H, Tagawa H, et al. Regulation of fibrillar collagen gene expression and protein accumulation in volume-overloaded cardiac hypertrophy. Circulation, 1997,95(10): 2 448
  • 5[5]Monkemann H, De vriese AS, Blom HJ, et al. Ear molecular events in development of the diabetic cardiomyopathy. Amino Acids, 2002, 23(1-3): 331
  • 6[6]Iwami K, Ashizawa N.Comparison of AngⅡ with the growth factors on Egrl and Matrix gene expression in cardiac fibroblasts. Am J Physiol, 1996,270:H2 100
  • 7[7]Van Boven AJ. Reduction of transient myocardial ischemic with pravastatin addition to the conventional treatment with angina pectoris. Circulation,1996,94:1 503
  • 8[8]Podar T, Tuomilehto J. The role of angiotensin converting enzyme inhibitors and angiotensin Ⅱreceptor antagonists in the management of diabetic complications. Drugs, 2002,62(14):2 007
  • 9[9]Lacoste L. Hperlipidemia and coronary disease, Correction of the increased thrombogenic potential with cholesterol reduction. Circulation,1995,92:3 172
  • 10[10]Gotto Jr AM. Drug development report (6).Provastatin:a hydrophilic inhibitor of cholesterol synthesis. J Drug Dev, 1990,3:153

共引文献7

同被引文献16

  • 1招少枫,江钟立,王磊.饮食和运动干预对2型糖尿病大鼠心肌Bcl-2和Bax表达的影响[J].中国康复医学杂志,2006,21(5):393-397. 被引量:11
  • 2LV C W J L.Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. European Journal of Pharmacology . 2009
  • 3Kong WJ,Zhang H,Song DQ, et al.Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism . 2009
  • 4Yang J,Dai C,Liu Y,et al.Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis in mice. Journal of the American Society of Nephrology . 2002
  • 5Ichihara S,Senbonmatsu T,Price E Jr,et al.Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation . 2001
  • 6G Zhou,X Li,DW Hein,X Xiang,JP Marshall,SD Prabhu.Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. Journal of the American College of Cardiology . 2008
  • 7Fang Z Y, Prins J B, Marwick T H. Diabetic cardiomyoPathy.. evidence, mechanisms, and therapeutic implications[J]. Endocr Rev, 2004,25(4) .. 543-567.
  • 8Way K J, Isshiki K, Suzuma K, et al. Expression of connective tissue growth factor is increased in injured myo- cardium associated with protein kinase C 2 activation and diabetes[J]. Diabetes, 2002,51 (9) : 2709-2718.
  • 9Nunoda S, Genda A, Sugihara N, et al. Quantitative approach to the histopathology of the biopsied right ven- tricular myocardium in patients with diabetes mellitus[J]. Heart and Vessels, 1985,1(1):43-.47.
  • 10Nakayama H, Morozumi T, Nanto S, et al. Abnormal myocardial free fatty acid utilization deteriorates with mor- phological changes in the hypertensive heart[J]. Jpn Circ J, 2001,65(9) : 783-787.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部